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Renal kallikrein mRNA localization by in situ hybridization. Tissue
kallikrein gene expression in rat kidney was examined by in situ
hybridization histochemistry. A rat tissue kallikrein cDNA probe, 534
bases in length and complementary to the 3' end of kallikrein mRNA
was first used in Northern blot analysis to demonstrate the existence of
tissue kallikrein mRNA in rat kidney. Then, kallikrein mRNA's local-
ization in rat kidney sections was studied in situ hybridization histo-
chemistry using the same probe. Positive signals were concentrated in
the renal cortex at the vascular pole of the glomeruli and to a lesser
degree, the distal tubular cells. Prehybridization with the unlabeled
probe can abolish the positive signal; the same result can also be
achieved by pretreatment of the tissue section with ribonuclease. By
using the same technique, tissue kallikrein mRNA was also localized in
granular convoluted tubule and striated duct cells of rat submandibular
gland. The results suggest a new site of renal kallikrein synthesis at the
vascular pole of the glomerulus. These findings, coupled with the
previous studies that tissue kallikrein can participate in activation and
releasing of renin, raise a potential physiological role of kallikrein in
renin release or prorenin processing at juxtaglomerular cells.
The renal kallikrein-kinin system is thought to play an impor-
tant role in the regulation of renal blood flow, water and sodium
excretion and the release of renin [1—4]. A correlation has also
been observed between the levels of urinary kallikrein excre-
tion and changes in blood pressure [5]. Nevertheless, the
precise mechanism of kallikrein's action in these systems has
not been positively established due, in part, to the fact that our
current knowledge of renal kallikrein localization is limited.
Being a crucial aspect to the understanding of its function, the
localization of kallikrein has been an issue of interest for
decades. Kallikrein has been identified at distal tubules by
immunohistochemistry in rat and human [6, 7], by micropunc-
ture technique in rat [8], stop-flow studies in dog (9], and
microdisection technique in rabbit F 10—121. Yet, localization has
also been reported at glomeruli by enzyme activity measure-
ment [13, 14] and immunohistochemistry [15]. However, dem-
onstration of either tissue kallikrein activity orantigenicity does
not necessarily prove its sites of synthesis since the protein may
originate at other place and then be transferred to the region
where it is detected. In situ hybridization, on the other hand,
can directly reveal the existence of a specific mRNA, which
reflects the origin of protein synthesis [16].
To identify the sites of kallikrein synthesis, in situ hybridiza-
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tion histochemistry [16, 17] was employed by using a rat tissue
kallikrein cDNA as a probe. Tissue kallikrein mRNA was
identified in the glomeruli in addition to previously described
sites of distal tubules by in situ hybridization histochemistry.
Methods
Tissue treatment
Female Sprague-Dawley rats (200 to 250 g, Charles River
Breeding Laboratories, Wilmington, Massachusetts, USA)
were anesthetized with sodium pentobarbital (50 mg/kg body
weight, i.p.) and perfused intracardially with 50 ml of normal
saline followed by 2% calcium acetate-buffered 4% formalde-
hyde (CAF), pH 7.4 for five minutes. The kidney and subman-
dibular gland were removed and cut into 2 mm-thick pieces,
postfixed by immersion in CAF for 30 minutes, and incubated
overnight in 70% ethanol at room temperature. The tissues were
then dehydrated through a series of increasing ethanol concen-
trations, incubated in absolute ethanol for 90 minutes with three
changes, xylene 90 minutes with two changes, paraffin 90
minutes with two changes and subsequently embedded in
paraffin at 62°C. Five micrometer sections were cut using a
rotary microtome (Reichert Histostat) and mounted on chrome
alum-coated glass microscopic slides. The slides were baked at
60°C for 60 minutes prior to use.
cDNA probe preparation and labeling
A cDNA clone encoding rat tissue kallikrein (RSK 1105) was
isolated from a rat submandibular gland cDNA library and
sequenced as described previously [18]. The probe has 534
bases and codes for the 3' end of tissue kallikrein. The eDNA
insert was labeled with 15S-dATP to a specific activity of io
cpm/ug DNA using a random primed DNA labeling method
(Boehringer Mannheim, Indianapolis, Indiana, USA) (19, 20].
Northern blot analysis
RNA was prepared according to a modification of the guani-
dinium thiocyanate method as described previously [21, 221.
RNA hybridization analysis was carried out essentially as
described by Thomas [23]. Briefly, total RNA was denatured
with I tt glyoxal, electrophoresed through 1.5% agarose gels,
and transferred to nitrocellulose. The tissue kallikrein cDNA
probe (RSK 1105) was labeled with 32P-dCTP to a specific
activity of I to 2 x j7 cpm/ig DNA by nick-translation
according to the procedure described by Weinstock et al [241.
Prehybridization and hybridization of the RNA blots with
32P-labeled kallikrein cDNA probe were performed in following
solution: 50% formamide, 5x SSC (lx SSC = 0.15 M sodium
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chloride, 0.015 M sodium citrate, pH 7.0), 50 mrt sodium
phosphate (pH 6.5), 200 gJml denatured salmon sperm DNA,
and lx Denhardt's solution (0.02% Ficoll, 0.02% polyvinylpyr-
rolidone and 0.02% bovine serum albumin). After 12 hours of
prehybridization at 42°C, ito 2 x 106cpmdenatured probe with
10% final concentration of dextran sulfate were added into the
solution and hybridized for 24 hours at the same temperature.
The hybridized blots were washed at room temperature with
four changes of 2x SSCIO.l% sodium dodecyl sulfate (SDS)for
five minutes and then with two changes of 0.1 X SSC/0.1% SDS
for 15 minutes at 50°C. The blots were dried and exposed to
Kodak X-Omat AR film with intensifying screens (Eastman
Kodak, Rochester, New York, USA) at —70°C for two days.
In situ hybridization
Modified procedures of Angerer, Cox and Angerer [171 were
used. Briefly, after rehydration, the slides were transferred into
a solution of proteinase K (1 pg/ml) in 100 mri Tris-HCI, pH 8.0
and 50 mtvt EDTA at 37°C for 25 minutes. The sections were
rinsed in distilled water and 0.1 M TEA buffer (0.1 M Trietha-
nolamine, pH 8.0), then incubated in 0.1 M TEA buffer with
0.25% (vol/vol) acetic anhydride for 10 minutes at room tem-
perature and followed by dehydration.
The radiolabeled probe was applied to the tissue sections in a
solution containing 10 mM Tris-HCI, pH 8.0, 1 mM EDTA, I x
Denhardt's solution, 10% dextran sulfate, 20 mM DTT (dithio-
threitol), 500 pg/mi yeast tRNA and 25% formamide. The probe
together with yeast tRNA, was denatured immediately before
use by boiling for three minutes and then cooling rapidly.
Twenty microliters of hybridization solution containing RSK
1105 with approximately 106 cpm radioactivity were applied to
the individual slide, which was then covered with a siliconized
coverslip and incubated in a moist chamber at 42°C overnight.
Next day, the coverslips were removed and slides were rinsed
briefly in 4x, 2x, and lx SSC. Then, they were incubated for
one hour each in 2x SSC and 0.lx SSC at 37°C, respectively,
followed by dehydration. In some experiments, the stringencies
of washing were varied by changing the concentration of SSC
used in final incubation from 0.1 x SSC to 0.5 x SSC in order to
achieve optimal results.
The specificity of the hybridization histochemistry was as-
sessed in two different ways. First, an unlabeled probe (RSK
1105, final concentration 6.6 ng/sl) was incorporated in the
hybridization buffer for prehybridization at 42°C for four hours
prior to hybridization with labeled probe. Second, some sec-
tions were incubated in 2 x SSC buffer containing 500 jig/mI
ribonuclease A and 50 U/mI ribonuclease T1 at 37°C for four
hours, then hybridized with kallikrein cDNA in the same way as
described above.
Autoradiography
Slides were dipped at 45°C in Kodak NTB-2 liquid nuclear
track emulsion diluted with an equal volume of 600 m ammo-
nium acetate. They were dried vertically for 30 minutes at room
temperature, incubated in a moist chamber for three hours at
room temperature to reduce the number of latent grains, placed
in light-tight slide boxes containing Drierite and exposed for
three to eight days at 4°C. The slides were developed in Kodak
D-19 developer for two minutes and fixed in Kodak fixer for five
minutes at 15°C. After washing for 30 minutes in cold running
Fig. 1. Northern blot analyses of kal!ikrein mRNA in female Sprague-
Dawley rat submandibular gland and kidney. Total RNA from rat
tissues was denatured, electrophoresed, and transferred to nitrocellu-
lose. The filter was then hybridized with nick-translated kallikrein
cDNA; the results were visualized by autoradiography. (1) 12 Lg rat
submandibular gland total RNA; (2) 12 sg rat kidney total RNA.
tap water, the sections were stained with hematoxylin and
dehydrated through an ethanol series, stained with eosin Y and
mounted in Permount.
Autoradiography grain counting
The autoradiography grain counting was executed by IBAS
program No. 444. The fields were imaged using standard
brightfield with a lOx Planachromat objective on a IM 35
inverted microscope (Zeiss, Oberkochen, FRG) and a medium
green interference filter. The video image was generated with a
Dage Series 68 high resolution monochrome camera (MTI,
USA) and digitized for image analysis at a resolution of 512 x
512 pixels and 256 grey levels. The image processing and
analysis was performed on an IBAS 2000 automatic image
analyzer (Zeiss).
The grains were first discriminated by dynamic grey level
discrimination with a concurrent automatic lowpass filter cor-
rection to cancel large area density differences caused by the
counterstain. The structures of interest were interactively dis-
criminated by the operator using the cursor and then automat-
ically measured for total area. The discriminated area image of
the structure was then used as a mask to designate only those
discriminated grains lying within the structure to be automati-
cally counted. The resulting count of significant positive grains
divided by total area gave a grain density measurement.
Results
Northern blot analysis using a tissue kallikrein cDNA probe
(RSK 1105) demonstrates the presence of tissue kailikrein
mRNA in rat kidney, as shown in Figure 1. The kallikrein
eDNA probe hybridized with only one class of kidney RNA
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Fig. 2. Sprague-Dawley rat kidney
section hybridized with rat tissue
kallikrein cDNA (RSK 1105).
Detailed experimental procedures
are described in the Methods.
Regions of high density silver grains
are localized within some of the
glomeruli (arrows). The section was
counterstained with hematoxylin
and eosin, 80x magnification.
which has a size similar to that of kallikrein RNA from
submandibular gland. The amount of kallikrein mRNA in rat
submandibular gland (lane I) was about 20-fold higher than that
in rat kidney (lane 2) according to densitometric scanning of the
autoradiograms when a equal amounts of total RNA (12 g)
from each tissue was applied to the gel. In the next step, the
specific cellular localization of tissue kallikrein mRNA in renal
tissue was determined by in situ hybridization histochemistry.
Figure 2 shows the rat renal tissue section hybridized with rat
tissue kallikrein cDNA. The positive signals expressed as high
density silver grain are observed within the glomeruli and they
appear more frequently at the superficial cortex. Serial sections
indicate that kallikrein is localized primarily over cells at the
vascular pole. It should be noted that neither afferent nor
efferent arterioles outside of glomeruli were labeled. No posi-
tive signals were found in the medullary region.
Figure 3A shows the positive signals over glomerulus of rat
renal tissue section at higher (400x) magnification. A group of
silver grains concentrated at the vascular pole of glomerulus.
The specificity of the hybridization is demonstrated by prehy-
bridization with excess amount of unlabeled rat tissue kallikrein
cDNA which eliminates the positive signal as shown in Figure
3B, Furthermore, some of the tissue sections were treated with
ribonucleases before hybridization. The results showed only
background signals (data not shown).
Positive signals are also observed, although less intensely, on
top of some distal tubules (Fig. 4). Since the contrast of grain
density between distal tubules and the adjacent structures is not
so obvious as compared to that in glomeruli, IBAS programed
autoradiography grain counting technique was used. On distal
tubules appear in Figure 4, the average value of grain density is
28.69 per 1,000 m2 and the average value of that for the
adjacent structures is 12.01 per 1,000 jsm2.
Rat submandibular gland tissue section was also hybridized
with tissue kallikrein cDNA for a positive control due to its
abundance of tissue kallikrein mRNA as shown in Figure 1.
Silver grains are localized at cells of granular convoluted
tubules and striated ducts when tissue section was hybridized
with the tissue kallikrein cDNA probe (Fig. 5). This result is
consistent with and further confirms the previous findings of
immunohistochemical localization of tissue kallikrein in rat
submandibular gland.
Discussion
The current study is the first demonstration of the presence of
tissue kallikrein mRNA at the vascular pole of glomeruli by in
situ hybridization. The existence of tissue kallikrein mRNA
most likely represents its translation as well, since there are
only rare circumstances in which a mRNA has been present in
a cell without expression [16].
Several previous studies have demonstrated kallikrein immu-
noreactivity and enzymatic activity in glbmeruli [13—15], while
other reports have only identified kallikrein at distal tubules [4,
6, 7, 9—12, 161. The present study, however, shows kallikrein
mRNA localization in glomeruli as well as distal tubules, One
possibility for the discrepancy is that once renal kallikrein is
synthesized at the glomeruli, it is rapidly secreted and trans-
ported to either the interstitial or urinary space to perform its
functions. Thus, the rapid excretion rate makes it difficult to
detect kallikrein or its enzymatic activity at the site of its origin.
This is not a unique phenomenon, since there are other proteins
that act in the similar way. For example, kininogen mRNA is
r 
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Fig. 3. (A) Glomerulus of rat kidney Section after in Sit,, hybridization with rat tissue kallikrein cDNA. Grains are concentrated above the vascular
pole region of glomerulus. Other structures are essentially negative. (B) Glomerulus on control section: the same type of tissue section was used
as in (A), but prehybridized with unlabeled probe in excess for competitive study. There are few dispersed grains on the tissue section. No region
with high density grains which stands for positive signal is observed. Both sections were counterstained by hematoxylin and eosin with 400x
magnifications.
found in the urine, there are several possible explanations.
Urinary kallikrein may come from distal tubules, since kalli-
krein and its mRNA have been localized at the distal nephron in
Fig. 4. Section of Sprague-Dawlev rat renal cortex kvhridized wit/I
tissue kallikrein cDNA. Silver grains are more concentrated on distal
tubules than that on other structures as demonstrated by 1BAS pro-
grammed autoradiography grain counting method: the grain density on
distal tubules averages 28.69 per 1,000 m2 while the average value of
that on other segments is 12.01 per 1,000 .tm2. D = Distal tubule; P =
Proximal tubule. (Hematoxylin and eosin stain, 200x magnification)
concentrated in rat liver, as demonstrated by Northern blot
analysis. However, only very low levels of kininogen are found
in the liver by Western blot analysis and radioimmunoassay in
contrast to the high levels of kininogen in blood and lung [251.
With respect to the origin of the high levels of renal kallikrein
several species. Alternatively, it may originate from the vascu-
lar pole and diffuse into the distal tubules through macula densa
or other structures. In addition, the possibility can not be
excluded that the tissue kallikrein observed in the urine may
have extrarenal origins [26].
Moreover, different methodologies have different sensitivi-
ties or resolutions [3] depending on the principles involved.
Therefore, the results should be critically evaluated. Enzyme
activity assays, even with synthetic substrate, have the problem
of nonspecificity [27]. Antibodies on the other hand are more
specific but do not bind membrane-bound kallikrein with the
same affinity as solubilized kallikrein [28]. At the same time,
variations in glycosylation might mask antigenic determinants
in the tissue. Physiological studies using the stop-flow tech-
nique have difficulty in determining the exact location of tubular
processes because of the heterogeneity of the cell population in
nephron [9]. In this aspect, in situ hybridization histochemistry
has a dual advantage in being able to directly localize mRNA,
and to employ the high specificity of nucleic acid hybridization.
However, in situ procedures are sensitive to the type or length
of probes used, the method of fixation and the condition of
hybridization and washing, and each of these factors must be
taken into consideration during the entire in situ hybridization
process.
At the vascular pole of the glomerulus, where tissue kalli-
krein mRNA was detected, there are peripolar cells described
by Ryan, Coghlan and Scoggins [29], which are situated in an
epithelial position, encircling the origin or polar region of the
.t. "In)
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Fig. 5. Rat submandibular gland
tissue section hybridized with tissue
kallikrein cDNA (RSK 1105) using
in situ hybridization histochemistry.
The silver grains are concentrated
over the granular convoluted tubule
and striated duct cells with low
background signals on other types
of cells. S = Striated duct; 0 =
Granular convoluted tubule.
(Hematoxylin stain, 200x
magnification)
glomerular tuft and interposed between podocytic and parietal
Bowman's capsular epithelium. It is likely that the positive
signals at the glomerulus may come from peripolar cells. In fact,
Gall et al [15] found tissue kallikrein in peripolar cells in sheep
by the immunohistochemical method. Besides, there is evi-
dence that peripolar cells have a secretory function and dis-
charge their contents into the urinary space under certain
conditions, such as sodium depletion in sheep [30] and diuresis
in new born lambs [31]. It is interesting to note that under the
same conditions, renal kallikrein excretion increases in several
species, including human [1, 2]. Whether this is a coincidence
or there is indeed a correlation between these two phenomena
needs to be further investigated. Work is underway in our
laboratory to identify the specific types of renal cells or nephron
segments which are capable of synthesizing tissue kallikrein.
The results reported here may be relevant to renal physiology
and pathophysiology since tissue kallikrein has been shown to
have a close relationship with the renin-angiotensin system [I—
4, 32—35]. It has been postulated that tissue kallikrein could
release renin in the kidney [1, 34] and participate in renin
activation [33, 35]. Our results provide an anatomical basis for
these hypotheses by revealing the close proximity of kallikrein
producing cells at the vascular pole and renin producing cells,
the juxtaglomerular cells, in the afferent arteriole wall.
Furthermore, kallikrein at the vascular pole may be released
into the interstitium causing kinin formation around the juxta-
glomerular apparatus, thereby changing the vascular tone of
afferent arteriole in vivo. In this case, the kallikrein-kinin
system could play a direct role in regulating renal blood flow
and glomerular filtration rate. If renal kallikrein synthesis and
excretion is decreased, an increase in renal circulatory resist-
ence will follow because the vasodilatation effect is decreased
due to a reduction in kinin formation [l-.4]. The higher resist-
ence of renal circulation could trigger other enzymatic and
hormonal systems which ultimately lead to renal and systemic
hypertension [36]. Although this is a simplified assumption, it
can explain the low rate of urinary kallikrein excretion in some
patients with essential hypertension [5].
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